The US government agency will hold roundtables with patient groups for each of the 15 impacted medicines and a town hall with clinicians before making any decision on the price reductions.
All manufacturers decide to participate in the second cycle of US price negotiation
March 19, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Can GLP-1s be more transformative than AI - one person believes they already are
July 14, 2026 - - Latest News -
The age-old argument for supermarket pharmacies misses the point, and the risks
July 14, 2026 - - Latest News -
Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers
July 13, 2026 - - Latest News -
Immutep cancer candidate shows strong median survival in lung cancer as company consider conflicting trial results
July 13, 2026 - - Australian Biotech -
OncoSil Medical establishes scalable Australian production after successful manufacturing validation
July 13, 2026 - - Australian Biotech -
SCENESSE gains Canadian approval offering long term protection for patients with rare disorder
July 13, 2026 - - Australian Biotech -
Patrys and Yale agree revenue share to advance deoxymab platform
July 13, 2026 - - Australian Biotech

